Acne is a nearly universal skin condition, yet its impact on emotional well-being and self-confidence can be profound at any age. It is more than just an aesthetic concern; severe acne can be painful, lead to permanent scarring, and cause significant emotional distress. While common, acne requires careful medical management because it involves a complex interplay of oil production, clogged pores, bacteria, and inflammation. 

Treatment is essential to relieve inflammation, clear current breakouts, and most importantly prevent the formation of scars, which are much harder to treat than the acne itself. Since acne ranges from mild blackheads to severe, painful cysts, medication choices are highly individualized. A successful treatment plan must be tailored to the patient’s severity, location of the acne, and whether underlying factors, such as hormonal cycles, are involved (American Academy of Dermatology, 2023). 

Overview of treatment options for Acne 

The main goal of acne treatment is achieving and maintaining clear skin by targeting the four causes of breakouts. For mild, non-inflammatory acne (blackheads and whiteheads), treatment typically starts with over-the-counter or prescription topical medications. 

For moderate acne that includes inflammatory papules and pustules, a combination therapy involving both topical agents and oral medications is usually necessary. Severe, scarring, or cystic acne often requires the strongest available oral drugs. Because the skin takes time to regenerate, treatment requires consistency and patience; clinical guidelines recommend a period of six to eight weeks before evaluating whether a treatment is working (National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2021). 

Medications used for Acne 

Pharmacological treatments fall into several major categories, often used in combination: 

  1. Topical Retinoids: These vitamin A derivatives (such as tretinoin and adapalene) are a cornerstone of treatment for all types of acne. They help unclog pores and keep new ones from forming. 
  1. Topical Antimicrobials: Benzoyl peroxide (BPO) kills the Cutibacterium acnes bacteria and helps remove excess oil. Topical antibiotics (like clindamycin) are often combined with BPO to reduce bacteria and minimize the risk of antibiotic resistance. 
  1. Oral Antibiotics: Drugs such as doxycycline and minocycline are used for moderate to severe inflammatory acne. They reduce bacteria across the body and decrease inflammation. These are typically used for short courses (3–4 months) to avoid long-term side effects. 
  1. Hormonal Agents: For women whose acne flares before their menstrual cycle, oral contraceptives or spironolactone may be prescribed. These medications work by decreasing the effect of androgen hormones, which trigger excess oil production. 
  1. Oral Retinoids: Isotretinoin is reserved for severe, resistant, or scarring cystic acne. It is the most effective acne treatment because it targets all four causes simultaneously. 

How these medications work 

Acne medications work by addressing the skin’s imbalance. Topical retinoids function as cell turnover regulators; they promote exfoliation deep within the pore lining, preventing skin cells from sticking together and creating clogs. This is known as the “unclogging” effect. 

Antimicrobial agents like BPO and oral antibiotics reduce the amount of acne-causing bacteria, which significantly lowers the inflammatory response (redness and swelling). Hormonal agents work by slowing down the production of sebum (oil) in the oil glands, starving the bacteria. The powerful oral retinoid, isotretinoin, drastically reduces the size and activity of the oil glands, resulting in a profound and long-lasting decrease in oil production. 

Side effects and safety considerations 

Side effects vary by medication. Topical retinoids commonly cause initial dryness, redness, peeling, and increased sun sensitivity. Oral antibiotics may cause stomach upset and increase sun sensitivity.  

The strong oral retinoid, isotretinoin, requires strict management due to potential side effects like severe dryness and is strictly contraindicated during pregnancy due to birth defect risks, necessitating strict pregnancy prevention and monthly lab monitoring (FDA, 2023). Patients on any acne treatment must seek immediate medical care for severe abdominal pain, sudden vision changes, or signs of an allergic reaction. 

Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care. 

References 

  1. American Academy of Dermatology. https://www.aad.org 
  1. Food and Drug Administration. https://www.fda.gov 
  1. Mayo Clinic. https://www.mayoclinic.org 
  1. National Institute of Arthritis and Musculoskeletal and Skin Diseases. https://www.niams.nih.gov

Medications for Acne

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Acne.

Found 11 Approved Drugs for Acne

ISOtretinoin

Brand Names
Amnesteem, Zenatane, Claravis, Accutane, Absorica

ISOtretinoin

Brand Names
Amnesteem, Zenatane, Claravis, Accutane, Absorica
ABSORICA and ABSORICA LD are indicated for the treatment of severe recalcitrant nodular acne in non-pregnant patients 12 years of age and older with multiple inflammatory nodules with a diameter of 5 mm or greater. Because of significant adverse reactions associated with its use, ABSORICA and ABSORICA LD are reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics. Limitations of Use : If a second course of ABSORICA/ABSORICA LD therapy is needed, it is not recommended before a two-month waiting period because the patient’s acne may continue to improve following a 15 to 20-week course of therapy [see Dosage and Administration.

Clindamycin

Brand Names
ClindaCare, Cleocin, Xaciato, Neuac, Clindacin ETZ, Tretinion, Clindesse, Clindacin, Tretinoin, Clindamycin Phoaphate, Altreno, Benzaclin, Atralin, Twyneo, ZIANA, Tri-Luma, Vesanoid, Retin-A, Clindagel, Acanya, Renova, Onexton

Clindamycin

Brand Names
ClindaCare, Cleocin, Xaciato, Neuac, Clindacin ETZ, Tretinion, Clindesse, Clindacin, Tretinoin, Clindamycin Phoaphate, Altreno, Benzaclin, Atralin, Twyneo, ZIANA, Tri-Luma, Vesanoid, Retin-A, Clindagel, Acanya, Renova, Onexton
TWYNEO is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 9 years of age and older. TWYNEO is a combination tretinoin, a retinoid, and benzoyl peroxide indicated for the topical treatment of acne vulgaris in adults and pediatric patients 9 years of age and older. ( 1 )

Minocycline

Brand Names
ZILXI, Emrosi, Amzeeq, Arestin, Minocin

Minocycline

Brand Names
ZILXI, Emrosi, Amzeeq, Arestin, Minocin
Minocycline hydrochloride tablets, USP are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms: Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox and tick fevers caused by rickettsiae. Respiratory tract infections caused by Mycoplasma pneumoniae. Lymphogranuloma venereum caused by Chlamydia trachomatis. Psittacosis (Ornithosis) due to Chlamydophila psittaci. Trachoma caused by Chlamydia trachomatis, although the infectious agent is not always eliminated, as judged by immunofluorescence. Inclusion conjunctivitis caused by Chlamydia trachomatis. Nongonococcal urethritis, endocervical, or rectal infections in adults caused by Ureaplasma urealyticum or Chlamydia trachomatis. Relapsing fever due to Borrelia recurrentis. Chancroid caused by Haemophilus ducreyi. Plague due to Yersinia pestis. Tularemia due to Francisella tularensis. Cholera caused by Vibrio cholerae. Campylobacter fetus infections caused by Campylobacter fetus. Brucellosis due to Brucella species (in conjunction with streptomycin). Bartonellosis due to Bartonella bacilliformis. Granuloma inguinale caused by Klebsiella granulomatis. Minocycline is indicated for the treatment of infections caused by the following gram-negative microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: Escherichia coli. Klebsiella aerogenes Shigella species. Acinetobacter species. Respiratory tract infections caused by Haemophilus influenzae. Respiratory tract and urinary tract infections caused by Klebsiella species. Minocycline hydrochloride tablets, USP are indicated for the treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: Upper respiratory tract infections caused by Streptococcus pneumoniae. Skin and skin structure infections caused by Staphylococcus aureus. (NOTE: Minocycline is not the drug of choice in the treatment of any type of staphylococcal infection.) When penicillin is contraindicated, minocycline is an alternative drug in the treatment of the following infections: Uncomplicated urethritis in men due to Neisseria gonorrhoeae and for the treatment of other gonococcal infections. Infections in women caused by Neisseria gonorrhoeae. Syphilis caused by Treponema pallidum subspecies pallidum. Yaws caused by Treponema pallidum subspecies pertenue. Listeriosis due to Listeria monocytogenes. Anthrax due to Bacillus anthraci s. Vincent’s infection caused by Fusobacterium fusiforme. Actinomycosis caused by Actinomyces israelii. Infections caused by Clostridium species. In acute intestinal amebiasis, minocycline may be a useful adjunct to amebicides. In severe acne, minocycline may be useful adjunctive therapy. Oral minocycline is indicated in the treatment of asymptomatic carriers of Neisseria meningitidis to eliminate meningococci from the nasopharynx. In order to preserve the usefulness of minocycline in the treatment of asymptomatic meningococcal carriers, diagnostic laboratory procedures, including serotyping and susceptibility testing, should be performed to establish the carrier state and the correct treatment. It is recommended that the prophylactic use of minocycline be reserved for situations in which the risk of meningococcal meningitis is high. Oral minocycline is not indicated for the treatment of meningococcal infection. Although no controlled clinical efficacy studies have been conducted, limited clinical data show that oral minocycline hydrochloride has been used successfully in the treatment of infections caused by Mycobacterium marinum. To reduce the development of drug-resistant bacteria and maintain the effectiveness of minocycline hydrochloride tablets, USP and other antibacterial drugs, minocycline hydrochloride tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Aczone

Generic Name
Dapsone

Aczone

Generic Name
Dapsone
Dapsone gel, 5%, is indicated for the topical treatment of acne vulgaris. Dapsone gel, 5% is indicated for the topical treatment of acne vulgaris.

Aklief

Generic Name
Trifarotene

Aklief

Generic Name
Trifarotene
AKLIEF Cream is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. AKLIEF Cream is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. ( 1 )
Showing 1-5 of 11
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances